Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024. In the quarter to June 2026, revenue fell 3.34%, EPS fell 37.5% and free cash flow grew 157.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.

59.95 0.88 −1.45%
Market cap
$5.7B
P/E
25.2×
Fwd P/E
16.5×
Dividend yield
2.40%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100

Insider Decisions trades per month

Total sells 14.67
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 4 5 — 3 — 1 4 1 1 5 1 1
Insider Ownership 38.14%

Capital & Financial Ratios $m

Market Cap 5,700.00
Revenue 1,354.36
Net Income 228.00
Free Cash Flow 361.13
Net Debt (739.54)
Current Ratio 3.19 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 25.19
Fwd P/E 16.50
P/S ratio 4.17
P/B ratio 2.18
Past 5Y EPS Growth 3.09%
This Y EPS Growth 1.90%
Next Y EPS Growth 6.00%
Next Y revenue growth 5.70%
Next 5Y EPS Growth 6.35%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 15.92%
10-year low 10-year high
P/S against its own 10 years 5.34%
10-year low 10-year high
P/B against its own 10 years 4.79%
10-year low 10-year high
EV/Sales against its own 10 years 5.79%
10-year low 10-year high
EV/FCF against its own 10 years 4.46%
10-year low 10-year high

Dividends

Payout Ratio 0.61
Annual Dividend Rate 1.44
Annual Dividend Yield 2.40%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 1.36
0.36
0.36
0.36
2025 1.35
0.33
0.33
0.33
0.36
2024 1.23
0.30
0.30
0.30
0.33
2023 1.11
0.27
0.27
0.27
0.30
2022 1.02
0.25
0.25
0.25
0.27
2021 0.91
0.22
0.22
0.22
0.25
2020 0.88
0.22
0.22
0.22
0.22
2019 0.79
0.19
0.19
0.19
0.22
2018 0.67
0.16
0.16
0.16
0.19
2017 0.58
0.14
0.14
0.14
0.16
2016 0.50
0.12
0.12
0.12
0.14
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 957 578 794 740
Receivables 262 315 331 285
Inventory 36 34 30 31
Other 182 197 181 207
1,488 1,194 1,388 1,326
2023 2024 2025 Q'26
Payables 21 17 18 12
ST’ Debt — — — —
Other 32 32 31 34
422 418 438 416

Compound Annual Growth %

10y 5y 3y
Sales 3.35% 3.04% 2.47%
Cash Flow 4.32% 6.55% 14.02%
Earnings 3.47% 1.97% 11.48%
Book Value 3.78% 1.54% 5.35%

Revenue $m

Dec Mar Jun Sep Year
’26 347 396 305 — —
’25 357 370 316 307 1,349
’24 316 365 289 305 1,274
’23 335 376 298 291 1,300
’22 352 334 290 278 1,254
’21 390 320 287 285 1,281
’20 292 352 247 271 1,162
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Dec Mar Jun Sep Year
’26 55 93 167 — —
’25 107 175 68 123 472
’24 8 181 21 116 327
’23 56 105 121 85 367
’22 32 63 173 51 319
’21 82 83 172 110 448
’20 31 66 134 113 344
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Dec Mar Jun Sep Year
’26 56 46 158 — —
’25 100 168 61 101 430
’24 2 172 14 109 297
’23 49 97 114 77 337
’22 6 51 161 41 259
’21 83 70 159 98 410
’20 7 45 120 102 275
Fiscal quarters ending in the months shown.

EPS $

Dec Mar Jun Sep Year
’26 0.55 0.99 0.30 — —
’25 0.70 0.94 0.48 0.51 2.62
’24 0.69 1.01 0.40 0.61 2.69
’23 0.82 0.98 0.17 0.09 2.05
’22 0.77 0.36 0.39 0.28 1.81
’21 1.30 0.73 0.52 0.42 2.97
’20 0.47 0.86 0.66 0.26 2.25
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to September

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 30.38 45.13 58.17 56.09 44.68 83.10 61.55 70.26 66.35 64.02

Analyst estimates 2026–2028

Powerpack
High 55.02 63.34 74.29 70.17 97.50 104.74 96.85 91.02 86.37 89.66
People
People Employees 2,030 2,122 2,151 2,193 2,289 2,368 2,336 2,246 2,080 2,051
Revenue/emp, $m 0.51 0.51 0.49 0.57 0.51 0.54 0.54 0.58 0.61 0.66
Income, $m
Income, $m Revenue 1,026 1,080 1,055 1,242 1,162 1,281 1,254 1,300 1,274 1,349
Gross margin, % 89.38 89.03 87.90 87.04 87.39 89.85 88.73 88.26 88.97 88.13
EBT 236 255 196 282 240 355 215 250 312 303
EBT margin, % 23.00 23.62 18.62 22.74 20.63 27.67 17.17 19.24 24.53 22.49
Net income 186 207 42 256 232 318 184 202 264 256
Depreciation 89 87 84 85 113 114 105 95 84 99
Per share, $
Per share, $ Revenue 10.18 10.61 10.20 12.22 11.55 12.66 12.54 13.57 13.33 14.07
Earnings 1.85 1.98 0.41 2.51 2.30 3.07 1.84 2.10 2.74 2.66
Cash flow 3.58 3.71 3.41 3.22 3.42 4.42 3.19 3.83 3.43 4.93
Capex (2.20) (1.03) (0.83) (1.12) (0.69) (0.38) (0.59) (0.32) (0.31) (0.44)
Free cash flow 1.37 2.68 2.58 2.11 2.73 4.05 2.59 3.52 3.11 4.49
Book value 19.65 21.06 22.93 22.76 24.25 25.74 22.51 24.77 26.03 27.45
Shares, m 101 102 103 102 101 101 100 96 96 96
Valuation, ×
Valuation, × P/E 29.35 29.08 150.83 25.75 28.69 28.66 35.41 38.43 28.03 27.21
P/S 5.33 5.45 6.79 5.29 5.74 6.95 5.20 5.95 5.74 5.14
P/B 2.76 2.75 3.02 2.84 2.73 3.42 2.89 3.26 2.94 2.64
EV/Sales 4.71 4.64 5.75 4.55 4.77 5.96 4.54 5.21 5.29 4.55
EV/FCF 34.90 18.35 22.71 26.36 20.15 18.75 21.99 20.82 23.57 14.28
Cash, $m
Cash, $m Operating cash flow 360 378 352 328 344 448 319 367 327 472
Capex (222) (105) (85) (114) (69) (38) (59) (30) (30) (42)
Free cash flow 138 273 267 214 275 410 259 337 297 430
Balance, $m
Balance, $m Working capital 547 766 1,211 1,075 1,280 1,445 1,033 1,066 777 950
Total debt — — — — 81 72 51 51 — —
Net debt (641) (882) (1,103) (925) (1,127) (1,272) (818) (957) (578) (794)
Shareholders’ equity 1,979 2,144 2,371 2,313 2,438 2,604 2,251 2,372 2,487 2,632
Returns, %
Returns, % ROA 8.37 8.53 1.55 8.97 8.06 10.30 6.35 7.08 8.60 8.05
ROIC 10.83 12.24 9.05 11.57 10.42 16.16 9.01 9.53 8.46 9.01
ROE 9.80 10.02 1.85 10.90 9.74 12.30 7.58 8.68 10.78 9.96
Negative figures in brackets.

All 10 years →

Fiscal years to Sep 2025 · latest quarter Jun 2026

Charts ten years each

Dolby Laboratories vs peers in Specialty Business Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
RTO Rentokil Initial PLC $10.5B 61.8× 29.4× +66.96% (above 0%: growing) +6.36% (above 0%: growing) +7.92% (above 0%: growing) 13.59% 0.00% Compare
DLB Dolby Laboratories $5.7B 25.2× 16.5× −3.34% (below 0%: shrinking) −37.50% (below 0%: shrinking) +157.37% (above 0%: growing) 86.78% 11.25%
AMTM Amentum Holdings, Inc. $4.7B 23.5× 21.9× −1.99% (below 0%: shrinking) +575.00% (above 0%: growing) +35.00% (above 0%: growing) 10.32% 4.93% Compare
UNF Unifirst Corporation $4.6B 39.7× 39.4× +3.87% (above 0%: growing) −48.20% (below 0%: shrinking) −21.68% (below 0%: shrinking) 37.00% 3.63% Compare
AZZ AZZ Inc. $3.9B 23.2× 22.1× +16.68% (above 0%: growing) −34.39% (below 0%: shrinking) +115.52% (above 0%: growing) 25.08% 17.21% Compare
FA First Advantage Corporation $3.5B 132× 67.8× +14.88% (above 0%: growing) +5,455.56% (above 0%: growing) +120.17% (above 0%: growing) 45.46% 12.71% Compare
MMS Maximus, Inc. $3.2B 9.0× 8.1× −5.15% (below 0%: shrinking) +4.81% (above 0%: growing) +30.90% (above 0%: growing) 27.27% 12.62% Compare
CBZ CBIZ, Inc. $3.0B 25.6× 12.1× −0.19% (below 0%: shrinking) −53.03% (below 0%: shrinking) +32.13% (above 0%: growing) 10.62% 4.99% Compare
ABM ABM Industries Incorporated $3.0B 18.4× 12.2× +4.19% (above 0%: growing) +25.37% (above 0%: growing) −13.91% (below 0%: shrinking) 12.35% 3.95% Compare
Median of peers $3.7B 24.6× 22.0× +4.03% +5.59% +31.52% 19.34% 4.96%

All 44 Specialty Business Services stocks →

Dolby Laboratories (DLB) key facts

  • Strength: Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
  • Dolby Laboratories (DLB) is a Specialty Business Services company in the Industrials sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, DLB traded at $59.95, a market capitalization of $5.7 billion.
  • Dolby Laboratories pays an annual dividend of $1.44 per share, a yield of 2.40%, with a payout ratio of 61.3%.
  • Return on equity was 9.96% and debt-to-equity 0.00.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 9.17 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Dolby Laboratories (DLB) Latest News

8 Aug

stockrow.com/DLB · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com